Search | Médecins Sans Frontières Access Campaign

33 results found

97% of the medicines MSF uses to treat people with HIV are generics made in India.

Infographic

MSF and generic medicines

Tags Intellectual property and trade drug-resistant TBHIV/AIDS free trade agreementgeneric medicinesRegional Comprehensive Economic Partnership (RCEP)

Metro advertisements for Doctors Without Borders, 2015

Press release |

29 July 2015

MSF to TPP Trade Ministers: Don’t create new monopolies for biologic medicines at the "final’ TPP negotiations in Hawaii

Tags Intellectual property and trade HIV/AIDStuberculosis access to medicinesfree trade agreementgeneric medicinesintellectual property & tradeTrans-Pacific Partnership Agreement (TPP)

Opinion article |

24 July 2015

TPP: Don’t trade away health

Tags Intellectual property and trade tuberculosishepatitis CHIV/AIDS evergreeningfree trade agreementintellectual property & tradeTrans-Pacific Partnership Agreement (TPP)

Opinion article |

24 July 2015

Why the TPP trade deal is a threat to public health

Tags Intellectual property and trade HIV/AIDS free trade agreementgeneric medicinesintellectual property & tradeTrans-Pacific Partnership Agreement (TPP) Democratic Republic of the Congo

Statement |

30 April 2014

MSF responds to US Trade 301 Watch List

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines evergreeningfree trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFARPHARMACEUTICAL Companies India

Statement |

02 April 2014

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFAR India

A boy with HIV is examined at Dawei clinic.

Press release |

15 July 2013

Trans-Pacific trade agreement could choke off patient access to affordable generic medicines

Tags Intellectual property and trade HIV/AIDS evergreeningfree trade agreementTrans-Pacific Partnership Agreement (TPP)

Statement |

27 June 2013

Oral Testimony at US Congressional Hearing: “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting U.S. Companies.”

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines compulsory licencefree trade agreementuniversal access Novartis India

Speech |

10 February 2012

Submission to the US Trade Representative Regarding the 2012 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines Anti-Counterfeiting Trade Agreement (ACTA)free trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFAR

Report |

18 July 2011

Untangling the Web of Antiretroviral Price Reductions 14th Edition

Tags HIV/AIDSIntellectual property and tradeResearch and development HIV/AIDS antiretroviral medicines compulsory licencefree trade agreement Untangling the Web of Antiretroviral Price Reductions

March against the Free Trade Negotiation between India and the EU.

Press release |

22 June 2011

India Says 'No' to Policy that Would Block Access to Affordable Medicines

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreement India

Press release |

07 April 2011

Europe Opens New Front Against Affordable Medicines in Trade Deal With India

Tags HIV/AIDSIntellectual property and trade HIV/AIDS free trade agreement European UnionIndia

Video |

29 March 2011

Marching for Generics

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreement India

Statement |

10 March 2011

MSF Oral Statement Regarding the 2011 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreement

Research article |

14 January 2011

The reality behind the rhetoric: How European policies risk harming access to generic medicines in developing countries

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines Anti-Counterfeiting Trade Agreement (ACTA)data exclusivityfree trade agreement

Report |

04 January 2011

10 Stories that Mattered to Access to Medicines in 2010

Tags Intellectual property and trade severe malariatuberculosismeaslesHIV/AIDS vaccines free trade agreementpatent pool

Press release |

10 December 2010

At EU-India Summit, European Negotiators Urged Not to Block Access to Affordable Medicines

Tags HIV/AIDSIntellectual property and trade HIV/AIDS free trade agreement European UnionIndia

Letter |

19 October 2010

DNP+ Letter to Indian Prime Minister

Tags Intellectual property and trade HIV/AIDS free trade agreement IndiaEuropean Union

Video |

15 October 2010

MSF International President says "Europe! Hands Off Our Medicine"

Tags Intellectual property and trade HIV/AIDS free trade agreement European UnionIndia

Press release |

05 May 2010

Victory for access to medicines as valganciclovir patent is rejected in India

Tags Intellectual property and trade HIV/AIDS valganciclovir free trade agreement Roche India

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF and generic medicines

MSF to TPP Trade Ministers: Don’t create new monopolies for biologic medicines at the "final’ TPP negotiations in Hawaii

TPP: Don’t trade away health

Why the TPP trade deal is a threat to public health

MSF responds to US Trade 301 Watch List

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

Trans-Pacific trade agreement could choke off patient access to affordable generic medicines

Oral Testimony at US Congressional Hearing: “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting U.S. Companies.”

Submission to the US Trade Representative Regarding the 2012 Special 301 Review Process

Untangling the Web of Antiretroviral Price Reductions 14th Edition

India Says 'No' to Policy that Would Block Access to Affordable Medicines

Europe Opens New Front Against Affordable Medicines in Trade Deal With India

Marching for Generics

MSF Oral Statement Regarding the 2011 Special 301 Review Process

The reality behind the rhetoric: How European policies risk harming access to generic medicines in developing countries

10 Stories that Mattered to Access to Medicines in 2010

At EU-India Summit, European Negotiators Urged Not to Block Access to Affordable Medicines

DNP+ Letter to Indian Prime Minister

MSF International President says "Europe! Hands Off Our Medicine"

Victory for access to medicines as valganciclovir patent is rejected in India